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A B S T R A C T   
Cardiac laminopathy caused by mutations in the LMNA gene are common and highly penetrant with a poor prognosis. We have generated a novel human induced 
pluripotent stem cell(iPSC) lines YCMi003-A from a patient with dilated cardiomyopathy associated with genetic variant LMNA c.1090G > C; p.Asp364His. We 
reprogrammed patient-specific peripheral blood mononuclear cells using five episomal vectors Oct4, Sox2, Lin28, L-Myc, and Klf4. The reported iPSC line would be a 
useful model for in vitro modeling of cardiac laminopathy.   
Resource Table:  
Unique stem cell line identifier YCMi003-A 
Alternative name(s) of stem cell 
line 
YCMi003-hDCM003-A 
Institution Yonsei University College of Medicine 
Contact information of 
distributor 
Seung-Hyun Lee, tiger815@yuhs.ac 
Type of cell line iPSC 
Origin human 
Additional origin info required 




Cell Source Peripheral blood mononuclear cells (PBMCs) 
Clonality Clonal 
Method of reprogramming Episomal plasmid vectors, Transgene-free 
Associated disease Dilated cardiomyopathy 
Gene/locus Heterozygous mutation in LMNA gene 
(NM_005572.3) / c.1090G > C, p.Asp364His 
Date archived/stock date April 2021 
Cell line repository/bank https://hpscreg.eu/cell-line/YCMi003-A 
Ethical approval 
(continued on next column)  
(continued ) 
Unique stem cell line identifier YCMi003-A 
Ethical committee: Yonsei University Health 
System, Severance Hospital, Institutional review 
board approval number: 4-2020-0112 
Ethical approval Ethical committee: Yonsei University Health 
System, Severance Hospital, Institutional review 
board approval number: 4-2020-0112   
1. Resource utility 
LMNA is responsible for gross nuclear abnormalities, including car-
diac laminopathy. This patient-specific induced pluripotent stem cell 
(iPSC) line, YCMi003-A, would be a useful cellular model for investi-
gating molecular mechanisms underlying the development of cardiac 
laminopathies. 
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2. Resource details 
The LMNA gene encodes lamin A and lamin C, which are principal 
structural components of nuclear lamina, and is associated with the 
pathogenesis of various laminopathies, including cardiac laminopathy 
and dilated cardiomyopathy. Familial cardiomyopathy associated with 
LMNA mutations accounts for approximately 6%–8% of idiopathic 
dilated cardiomyopathy cases (Hershberger and Siegfried, 2011), but 
the prognosis is worse than for other forms of dilated cardiomyopathy 
(Kayvanpour et al., 2017). Mutations in LMNA are associated with 
several cellular signaling and gene expression issues in the heart (Lee 
et al., 2019; Shah et al., 2021). Therefore, it is crucial to generate iPSCs 
of patients with LMNA genetic mutations to elucidate the disease 
mechanism of cardiac laminopathy. This study establishes a novel iPSC, 
YCMi003-A, carrying genetic variant LMNA p.Asp364His with dilated 
cardiomyopathy. Peripheral blood mononuclear cells (PBMCs) were 
Fig. 1.  
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isolated from a 41-year-old male patient with familial dilated cardio-
myopathy. PBMCs were reprogrammed using Epi5 Episomal iPSC 
Reprogramming Kit (Thermo Fisher Scientific) containing five reprog-
ramming factors (Oct4, Sox2, Lin28, Klf4, and L-Myc). After reprog-
ramming, the YCMi003-A line showed typical hESC-like morphology. 
Alkaline phosphatase expression was evaluated using the Alkaline 
Phosphatase Live stain kit (Thermo Fisher Scientific) (Fig. 1A). Immu-
nofluorescence staining confirmed the expression of essential pluripo-
tent markers, including OCT4, SOX2, SSEA4, and TRA-1–60 (Fig. 1B). 
Quantitative real-time PCR (qRT-PCR) analysis confirmed iPSCs 
expressed endogenous pluripotency genes, including SOX2, DNMT3B, 
REX1, and TDGF1 (Fig. 1C). G band karyotyping analysis showed a 47, 
XYY in the iPSC line (Fig. 1D). In vitro differentiation into -
three germ layers, using the STEMdiffTM Trilineage Differentiation Kit 
(Stemcell Technologies, 05230), confirmed the pluripotency of 
YCMi003-A by detection of SOX17 (endoderm), Brachyury (mesoderm), 
and βIII-tubulin (ectoderm) expression, representing the three germ 
layers (Fig. 1E). Sanger sequencing also revealed the presence of a 
c.1090G > C change in exon 6 of the LMNA gene (Fig. 1F). The result of 
the mycoplasma test using RT-PCR was negative in the YCMi003-A iPSC 
line (Fig. 1G). The identity of this iPSC line was also confirmed using 
short tandem repeat (STR) analysis. 
3. Materials and methods 
Ethical statement 
Written informed consent was obtained from the patient and the 
study was approved by the Institutional Review Board (IRB) and ethics 
committee of the Yonsei University Health System (NO. 4–2020-0112). 
3.2. Reprogramming of human PBMCs 
A whole blood sample was obtained from a 41-year-old Korean male 
patient who had a missense mutation (D364H) in exon 6 of the LMNA 
gene. PBMCs were isolated using SepMateTM (StemCell Technologies, 
15410), according to the manufacturer’s recommendations. In brief, the 
fresh blood sample was diluted with an equal volume of PBS and then 
LymphoprepTM (StemCell Technologies, 07801) in the SepMate tube. It 
was centrifuged at 1200 g for 15 min at room temperature (RT), washed 
twice with 10 ml of PBS, and the cell pellet was resuspended in Erythroid 
Expansion Medium. The PBMCs were plated into wells of a six-well plate 
with fresh medium for seven days. The integrating-free Epi5TM Episomal 
iPSC Reprogramming Kit (Thermo Fisher Scientific, A15960) with the 
electroporation system (Neon Electroporation) was used for reprog-
ramming, according to the manufacturer’s recommendations. The kit 
contains an optimized mixture of three episomal vectors that deliver five 
reprogramming factors: Oct4, Sox2, Klf4, L-Myc, and Lin28. Cells were 
then plated in a six-well plate coated with Corning Matrigel (hESC- 
qualifed, Corning, 356278). Daily medium changes, using ReproTeSRTM 
medium, were performed over 25 days. The cells were monitored until 
iPS cell colonies appeared. The obtained clones were cultured onto 
vitronectin coated plates (Truncated VTN-N recombinant human pro-
tein, Gibco, A31804) in TeSR™-E8™ medium (Stemcell Technologies, 
05990) at 37 ◦C in a 5% CO2 atmosphere. The cell culture medium was 
changed daily. Cells were passaged with ReLeSRTM (Stemcell Technol-
ogies, 05872) at a ratio of 1:10–1:20 every 4–5 days with 10 μM Y-27632 
(Tocris, 1254). 
3.3. Alkaline phosphatase analysis 
YCMi003-A cells were seeded on six-well Matrigel™ coated plates. 
On day 40 after reprogramming, cells were stained using the Alkaline 
Phosphatase Live stain kit (Thermo Fisher Scientific, A14353). Briefly, 
an appropriate amount of the stain solution was applied directly on to 
the iPSCs, incubated for 20 min, and then washed with DMEM/F-12. 
Plates were analyzed with a fluorescence microscope (OLYMPUS, IX71). 
3.4. Quantitative RT-PCR 
Total RNA was extracted using a Ribospin™ total RNA purification 
kit (GeneAll Biotechnology, 314–150) from iPSCs at passage 12. Reverse 
transcription was performed with PrimeScriptTM Reverse Transcriptase 
(Takara, 2680A), according to the manufacturer’s recommendations. 
The gene amplification was performed by a QuantStudioTM 3 Real-Time 
PCR system (Applied BiosystemsTM, A28567) using FastStart Universal 
SYBR® Green Master (Roche Applied Science). The expression of an 
endogenous control gene (GAPDH) and pluripotency-related genes 
(SOX2, DNMT3B, REX1, and TDGF1) were amplified using the primers 
listed in Table 2. Validated human iPSC (CMC-hiPSC-011) was used as a 
positive control. 
Table 1 
Characterization and validation.  
Classification Test Result Data 
Morphology Photography Bright field Normal Fig. 1 panel A 
Phenotype Qualitative analysis 
Immunocytochemistry 
Positive for pluripotency markers including 
OCT4, SOX2, SSEA4, and TRA-1–60 
Fig. 1 panel B 
Quantitative analysis 
RT-qPCR 
Positive for SOX2, DNMT3B, REX1, TDGF1 Fig. 1 panel C 
Genotype Karyotype (G-banding) and resolution 46XYY, Resolution 450–500 Fig. 1 panel D 
Identity Microsatellite PCR (mPCR) OR Not Performed NA 
STR analysis 16 loci tested, all matched Submitted in archive 
with journal 
Mutation analysis Sequencing Heterozygous mutation Fig. 1 panel F 
Southern Blot OR WGS NA NA 
Microbiology and 
virology 
Mycoplasma Mycoplasma testing by RT-PCR, Negative Fig. 1 panel G 
Differentiation potential Directed differentiation Endoderm: αSOX17 
Mesoderm: αBrachyury 
Ectoderm: αβIII-tubulin 
Fig. 1 panel E 
List of recommended 
germ layer markers 
Expression of these markers has to be demonstrated at mRNA (RT PCR) 
or protein (IF) levels, at least 2 markers need to be shown per germ layer 
Endoderm: αSOX17Mesoderm: αBrachyury 
Ectoderm: αβIII-tubulin 




HIV 1 + 2 Hepatitis B, Hepatitis C Negative Not shown but 
available with author 
Genotype additional info 
(OPTIONAL) 
Blood group genotyping Not performed NA 
HLA tissue typing Not performed NA  
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3.5. Immunocytochemistry 
Passage 12 iPSCs were fixed using 4% paraformaldehyde for 20 min, 
blocked with 3% bovine serum albumin (LPS solution, 9048–46-8) with 
0.3% Triton X (USB®, 9002–93-1), and incubated overnight at 4 ◦C with 
primary antibodies for OCT4, SOX2, SSEA4, and Tra-1–60. Then, 
Alexa® Fluor 488 chicken anti-rabbit IgG (1:500, Thermo Fisher Sci-
entific, A21441) or Alexa® Flour 546 goat anti-mouse IgG (1:500, 
Thermo Fisher Scientific, A11030) as a secondary antibody for 3 h at RT. 
Hoechst 33,342 (Thermo Fisher Scientific, 62249) was used for coun-
terstaining the nuclei of cells for 10 min at RT. Slides were analyzed with 
a confocal microscope (LSM710, Zeiss) using ZEN software. All antibody 
information is listed in Table 2. 
3.6. Sequencing of the mutation site 
Genomic DNA was extracted from YCMi003-A using the G-spin™ 
Genomic DNA Extraction Kit (iNtRON Biotechnology, 17121), following 
the manufacturer’s instructions. After PCR amplification of exon 6–7 of 
the LMNA gene, specific primers were prepared and the mutation site 
was identified through Sanger Sequencing. The specific primers are 
listed in Table 2. 
3.7. Karyotyping 
Passage 12 iPSCs were treated with KaryoMAX Colcemid (Thermo 
Fisher Scientific) for 76 min at 37 ◦C and then dissociated using Gentle 
Cell Dissociation Reagent (Stemcell Technologies, 07174). Single- 
dissociated iPSCs were washed in 3 ml PBS and incubated at 37 ◦C in 
0.1 M hypotonic KCL solution for 30 min. They were then fixed with 
FIXATION buffer for 5 min. The karyotype of iPSCs was analyzed using 
Ikaros (MetaSystems, Neon 1.2.7) software with a 450–500 band 
resolution. 
3.8. In vitro trilineage differentiation 
Directed in vitro trilineage differentiation was achieved using the 
STEMdiffTM Trilineage Differentiation Kit (Stemcell Technologies, 
05230), according to manufacturer’s instructions. In brief, single- 
dissociated iPSCs were seeded onto a Matrigel coated 12-well plate. 
Cells were cultured in lineage-specific medium with daily replacement 
until day five, for mesodermal (200,000 cells/well) and endodermal 
(800,000 cells/well), and until day seven for ectodermal (800,000 cells/ 
well) differentiation. To assess trilineage differentiation, RT-PCR of 
lineage-specific markers and immunofluorescence assays were per-
formed (Table 1). 
3.9. STR analysis 
An STR analysis was performed on the iPSCs and the parental 
PBMCs, with detection of 16 loci (D8S1179, D21S11, D7S820, CSF1PO, 
D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, 
D18S51, AMEL, D5S818). In brief, PCR was used to amplify the STR loci. 
The PCR products were analyzed with Gene Mapper Software 5 (Applied 
Biosystems, 5.0) software. 
3.10. Mycoplasma screening 
Mycoplasma was detected using TaKaRa PCR Mycoplasma Detection 
Set (Takara, 6601), according to the manufacturer’s recommendations. 
In brief, the PCR product (8 µl) was loaded onto 1% agarose gel for 
electrophoresis. The correct size band indicates the presence of myco-
plasma species in the cell culture. 
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Table 2 
Reagents details.   
Antibodies used for immunocytochemistry/flow-cytometry  
































Goat IgG anti- 
hSOX17 
1:100 R&D Systems 
Cat# AF1924 
AB_355060 
Goat IgG anti- 
h/mBrachyury 













546 goat anti- 
mouse IgG 





Target Size of 
band 





SOX2 215 bp 5′- TGG ACA GTT ACGC GC 
ACA T − 3′
5′- ACC TAC AGC ATG TCC TAC 
TCG − 3′
DNMT3B 199 bp 5′- CCC AGC TGT TAC CTT ACC 
ATC G − 3′
5′- GGT CCC CTA TTC CAA ACT 
CCT − 3′
REX1 210 bp 5′- GCA GCC ACG GCC TAT TAA 
G − 3′
5′- CCA CCA CGT ACT TGC CAC 
T − 3′
TDGF1 96 bp 5′- ACA GCA CAG TAA GGA 
GCT AAA C − 3′
5′- CGT CCG TAG AAG GAG 
GGA GG − 3′
House-Keeping 
Genes (qPCR) 
GAPDH 197 bp 5′- GGA GCG AGA TCC CTC 
CAA AAT − 3′
5′- GGC TGT TGT CAT ACT TCT 




LMNA exon 6 – 
7 
524 bp 5′- TGC TGA GAG GAA CAG 
CAA − 3′
5′- CAA ACT TGC CCT CCT CAT 
− 3′
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(Korea National Institute of Health), originally provided from Catholic 
University. 
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